CytomX Therapeutics (CTMX) Tax Provisions (2015 - 2026)
CytomX Therapeutics (CTMX) reported Tax Provisions of $60,000 for Q2 2026, down 4.8% from $63,000 a year earlier but up 1.7% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Tax Provisions (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CytomX Therapeutics' Tax Provisions came in at $231,000, down 6.9% year-over-year; for FY2025, it was $238,000, up 6.3% from FY2024.
- By year, Tax Provisions came in at $224,000 in FY2024 (-94.2%) and $3.89 million in FY2023.
- Five-year quarterly Tax Provisions spans a low of $49,000 in Q1 2024 and a high of $2.82 million in Q3 2023.
- Year over year, Tax Provisions has now declined in each of the last four quarters, with an average decline of 21.2% over the last eight quarters.
- The high point for year-over-year Tax Provisions in five years was Q1 2025 (growth of 26.5%); the low point was Q3 2024 (a decline of 97.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $59,000 (Q1 2026), $54,000 (Q4 2025) and $58,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 292.00 Mn |
| 10 | CytomX Therapeutics | 599.22 Mn | -358.44 Mn | - | 60,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Mar 31, 2020 | -13.91 Mn |
| Dec 31, 2019 | -421,000.00 |
| Mar 31, 2019 | -6,000.00 |
| Dec 31, 2018 | 8.91 Mn |
| Sep 30, 2018 | 2.50 Mn |
| Jun 30, 2018 | 1.80 Mn |
| Mar 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | -520,000.00 |
API Access
CytomX Therapeutics Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();